Drugs / sodium antimony gluconate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01240473 | Apr 2007 → Mar 2008 | visceral leishmaniasis | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium antimony gluconate | “In Bangladesh, intramuscular administration of sodium antimony gluconate (SAG; Albert David Ltd., India), in a dose of 20 mg/kg body weight, with a maximum dose of 850 mg/day,...” NCT01240473 ↗ |
| Known as | SAG | “In Bangladesh, intramuscular administration of sodium antimony gluconate (SAG; Albert David Ltd., India), in a dose of 20 mg/kg body weight, with a maximum dose of 850 mg/day,...” NCT01240473 ↗ |
| Route | Intramuscular | “intramuscular administration of sodium antimony gluconate” NCT01240473 ↗ |